Page results
-
The Interventional Oncology Service (IOS) at University College London Hospital (UCLH) is committed to improving the experience and outcomes for patients with cancer through cutting edge image guided interventions.
-
Evidence shows that in selected cases open fetal surgery to close the spina bifida defect improves baby outcomes compared to surgery after birth.
-
Our andrology unit manages patients with andrological conditions including male sterilisation and infertility service, and other disorders of the penis or male genitalia.
-
We offer management of kidney stone disease, including in-house lithotripsy, rigid ureteroscopy, flexible ureterorenoscopy and laser disintegration of stones in ureters and kidneys and percutaneous nephrolithotomy.
-
The Preterm Birth Clinic is one of a few UK specialist antenatal services that are designed specifically for the needs of pregnant women at risk of premature labour.
-
In partnership with Camden MSK, our department has agreed to provide ultrasound-guided joint and soft tissue injections to patients referred by the Camden community MSK services.
-
The London Sarcoma Service is one of the largest sarcoma services in Europe with an international reputation for providing the highest quality of care to patients with sarcoma.
-
Spinal tumours can cause pressure on the spinal cord and/or nerves and depending on where the tumour is in your spine, different areas of your body can be affected.
-
This booklet explains what you can expect during recovery from your autologous stem cell transplant.
-
The TB network for north central London aims to reduce the capital’s high number of new cases and making it easier for patients to receive treatment.
File results
-
FOI/2022/0207 - Patient treatment with Nivolumab
-
FOI/2022/0209 - Patient tracking list or waiting lists
-
FOI/2022/0211 - Enteral feeding machine mechanical insufflator
-
FOI/2022/0212 - Clotting disorders medication
-
FOI/2022/0214 - Prostate Cancer (Summary Funding and costs of Xtandi (Enzalutamide) trial: NCT00974311) Xtandi (Enzalutamide) trial, NCT00974311
-
FOI/2022/0217 - Medications for dermatological conditions
-
FOI/2022/0221 - Asthma medications
-
FOI/2022/0223 - Policies/ procedures for management of patients with chest pain
-
FOI/2022/0224 - Procurement for physiotherapy, occupational therapy, pharmacy, radiography, speech and language therapy and sterile services
-
FOI/2022/0226 - Treatments for Haemophilia A